Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | RARB | P10826 | 2/20 | 0.32 |
| ▸ | RARG | P13631 | 2/20 | 0.32 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | RARA | P10276 | 1/20 | 0.32 |
| ▸ | CRABP2 | P29373 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4366145 | 0.84 | MAOA (0.36) | MAOAMAOBIDO1 | |
| SCHEMBL164856 | 0.77 | MAOA (0.35) | MAOAMAOB | |
| SCHEMBL11448674 | 0.77 | MAOA (0.35) | MAOAMAOB | |
| SCHEMBL11456623 | 0.77 | MAOA (0.35) | MAOAMAOB | |
| SCHEMBL11447991 | 0.77 | MAOA (0.35) | MAOAMAOB | |
| SCHEMBL754466 | 0.77 | MAPT (0.39) | MAOACYP3A4KDM4EALDH1A1GLA | |
| SCHEMBL13966472 | 0.77 | PTGS1 (0.33) | MAOAMAOBALDH1A1 | |
| SCHEMBL11448798 | 0.77 | MAOA (0.35) | MAOAMAOB | |
| SCHEMBL5980823 | 0.77 | MAOA (0.35) | MAOAMAOB | |
| SCHEMBL19433844 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| US-20220000103-A1 | Compositions and Methods for Modulating Root Growth | DUKE UNIVERSITY | 2022-01-06 | — | — | US | claimed |
| EP-3876720-A1 | COMPOSITIONS AND METHODS FOR MODULATING ROOT GROWTH | Duke University (US) | 2021-09-15 | — | — | EP | claimed |
| US-20190289849-A1 | Novel Plant Growth Regulators and Methods of Using Same | DUKE UNIVERSITY | 2019-09-26 | — | — | US | claimed |
| EP-3458592-A1 | NOVEL PLANT GROWTH REGULATORS AND METHODS OF USING SAME | Duke University (US) | 2019-03-27 | — | — | EP | claimed |
| WO-2017201410-A1 | NOVEL PLANT GROWTH REGULATORS AND METHODS OF USING SAME | DUKE UNIVERSITY (US) | 2017-11-23 | — | — | WO | claimed |
| EP-2652102-B1 | MOC COMPOSITIONS | GIVAUDAN SA (CH) | 2016-09-14 | — | — | EP | claimed |
| EP-2020225-B1 | Fragrance composition | KAO CORP (JP) | 2014-10-08 | — | — | EP | claimed |
| EP-1737937-B1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2013-06-12 | — | — | EP | claimed |
| CN-101579292-A | Perfume composition | KAO CORP (JP) | 2009-11-18 | — | — | CN | claimed |
| EP-1343466-B1 | PERFUME COMPOSITIONS | QUEST INT SERV BV (NL) | 2007-01-03 | — | — | EP | claimed |
| CN-1674862-A | Perfume composition | KAO CORP (JP) | 2005-09-28 | — | — | CN | claimed |
| EP-3458592-B1 | USE OF PLANT GROWTH REGULATORS | UNIV DUKE (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4526411-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | Symrise AG (DE) | 2025-03-26 | — | — | EP | disclosed |
| WO-2023224604-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | disclosed |
| US-6194375-B1 | VINYL ALCOHOL POLYMERS | QUEST INTERNATIONAL B.V. (NL) | 2001-02-27 | — | — | US | disclosed |
| US-6024943-A | POLYMER CORES WITH COATINGS | QUEST INTERNATIONAL B.V. (NL) | 2000-02-15 | — | — | US | disclosed |
| US-4369328-A | Oxygenated alicyclic compounds and process for preparing same | FIRMENICH SA (CH) | 1983-01-18 | — | — | US | disclosed |
| EP-0046606-A1 | Oxygenated alicyclic compounds, process for their preparation and their use as starting materials in the preparation of cyclohexadienic compounds | FIRMENICH SA (CH) | 1982-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220000103-A1 | Compositions and Methods for Modulating Root Growth | CROCC, CYCS, MYB | MAOA 609/4885MAOB 364/4885IDO1 2738/4885 |
| US-20190289849-A1 | Novel Plant Growth Regulators and Methods of Using Same | MYB, MYBBP1A, OSBPL3 | MAOA 2068/4885MAOB 1289/4885IDO1 3835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.